| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.08 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |